EUVIMEDEUVIMED entdecken
Open Access

Intralesional Bleomycin Injection Treatment of Intraabdominal Lymphangiomas Presenting with Acute Abdomen in Children

Rahşan Özcan, Ali Ekber Hakalmaz, Senol Emre, Ayten Ceren Bakır, Süreyya Aydın, Fatih Gulsen, Osman Faruk Senyuz, Gonca Topuzlu Tekant

Turkish Journal of Trauma and Emergency Surgery · 2023

DOI: 10.14744/tjtes.2022.37963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Trauma and Emergency Surgery, 2023. Verfasst von Rahşan Özcan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul-Türkiye. Hauptthemen laut MEDLINE: Abdomen, Acute, Lymphangioma. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We evaluated the results of urgent intralesional bleomycin injection (IBI) treatment of intra-abdominal lymphan-giomas (IAL) presenting with acute abdomen in children. METHODS: The records of patients who underwent urgent IBI due to acutely presenting IAL between January 2013 and January 2020 were reviewed retrospectively in terms of age, presenting symptoms, cyst type, number of injections, pre- and post-treatment cyst volume, clinical response, complications, and follow-up. RESULTS: Six patients with a mean age of 4.3 years (2-13 years) were treated. Presenting symptoms were acute abdominal pain (n=4), abdominal distention (n=1), hypoproteinemia and chylous ascites (n=1). Lesions were of macrocystic type in four and macro and micro cystic in two patients. The median number of injections performed was 2 (1-11). Mean cyst volume reduced dramatically from 567 cm3 (range 117-1656) to 3.4 cm3 (range 0-13.8) after treatment (p=0.028). Treatment response was excellent in four patients with complete resolution of the cysts, while good in the remaining two. No early or late complications or recurrence was observed in a mean follow-up period of 40 months (16-56 months). CONCLUSION: IBI is a safe, fast, and easily applicable method with satisfactory results in the treatment of acutely presenting IAL. It may be recommended in primary as well as recurrent lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abdomen, AcuteLymphangiomaHumansChildChild, PreschoolBleomycinRetrospective StudiesInjections, IntralesionalTreatment Outcome

Substanzen

Bleomycin

Autor:innen und Institutionen

  • Department of Pediatric Surgery, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul-Türkiye.
  • Department of Radiology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul-Türkiye.

Zitieren

APA

Özcan, R., Hakalmaz, A. E., Emre, S., Bakır, A. C., Aydın, S., Gulsen, F., Senyuz, O. F., & Topuzlu Tekant, G. (2023). Intralesional Bleomycin Injection Treatment of Intraabdominal Lymphangiomas Presenting with Acute Abdomen in Children. Turkish Journal of Trauma and Emergency Surgery. https://doi.org/10.14744/tjtes.2022.37963

Vancouver

Özcan R, Hakalmaz AE, Emre S, Bakır AC, Aydın S, Gulsen F, et al. Intralesional Bleomycin Injection Treatment of Intraabdominal Lymphangiomas Presenting with Acute Abdomen in Children. Turkish Journal of Trauma and Emergency Surgery. 2023. doi:10.14744/tjtes.2022.37963

BibTeX
@article{zcan2023,
  author = {Özcan, Rahşan and Hakalmaz, Ali Ekber and Emre, Senol and Bakır, Ayten Ceren and Aydın, Süreyya and Gulsen, Fatih and Senyuz, Osman Faruk and Topuzlu Tekant, Gonca},
  title = {Intralesional Bleomycin Injection Treatment of Intraabdominal Lymphangiomas Presenting with Acute Abdomen in Children},
  journal = {Turkish Journal of Trauma and Emergency Surgery},
  year = {2023},
  doi = {10.14744/tjtes.2022.37963}
}
Kostenlos starten →